Maravai LifeSciences Inc.
MRVI | NASDAQ
$7.17
+$0.20 (+2.87%)
At close: Sep 21, 2026, 4:00 PM ET
$7.30
+$0.13 (+1.81%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 216.89M | 322.4M | 574.96M | 632.14M | 551.27M | 236.18M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | 8.56M | 11.36M | n/a | n/a |
Other Long-Term Assets | 192.14M | 7.24M | 9.32M | 40.33M | 4.36M | 4.16M |
Receivables | 25.5M | 38.52M | 55.72M | 146.81M | 117.51M | 51.02M |
Inventory | 40.5M | 50.08M | 51.4M | 43.15M | 51.56M | 33.3M |
Other Current Assets | 13.37M | 18.15M | 17.83M | 25.8M | n/a | n/a |
Total Current Assets | 296.25M | 429.15M | 699.91M | 847.9M | 740.04M | 331.6M |
Property-Plant & Equipment | 1.22M | 217.03M | 222.65M | 116.59M | 95.43M | 101.31M |
Goodwill & Intangibles | 280.97M | 354.84M | 547.02M | 500.33M | 270.34M | 401.93M |
Total Long-Term Assets | 474.33M | 579.1M | 787.54M | 1.43B | 1.18B | 939.09M |
Total Assets | 770.58M | 1.01B | 1.49B | 2.28B | 1.92B | 1.27B |
Account Payables | n/a | 11.96M | 10.73M | 5.99M | 8.15M | 2.99M |
Deferred Revenue | n/a | 3.29M | 3.36M | 3.09M | 12.64M | 78.06M |
Short-Term Debt | 5.44M | 5.44M | 5.44M | 5.44M | 6M | 6M |
Other Current Liabilities | 39.48M | 18.71M | 47.62M | 69.48M | 18.89M | 4.17M |
Total Current Liabilities | 44.92M | 56.97M | 87.47M | 110.14M | 93.78M | 130.78M |
Long-Term Debt | 30.14M | 290.49M | 518.71M | 522M | 524.59M | 528.61M |
Other Long-Term Liabilities | 322.81M | 11.09M | 11.98M | 693.38M | 713.64M | 391.78M |
Total Long-Term Liabilities | 352.95M | 374.06M | 610.1M | 1.27B | 1.28B | 985.17M |
Total Liabilities | 397.87M | 431.04M | 697.57M | 1.38B | 1.37B | 1.12B |
Total Debt | 35.58M | 376.69M | 610.97M | 585.26M | 575.22M | 590.78M |
Book Value | 372.71M | 577.21M | 789.88M | 905.24M | 545.36M | 154.75M |
Book Value Per Share | 2.57 | 4.19 | 5.99 | 6.87 | 4.47 | 1.60 |
Common Stock | 2.56M | 2.53M | 2.51M | 2.55M | 2.55M | 2.58M |
Retained Earnings | 10.12M | 140.89M | 285.74M | 404.77M | 184.56M | 854K |
Comprehensive Income | 524K | n/a | n/a | n/a | n/a | -44K |
Shareholders Equity | 212.38M | 325.29M | 416.75M | 545.22M | 315.5M | 88.51M |
Total Investments | n/a | n/a | 8.56M | 11.36M | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove MRVI